SJR76 Alabama 2026 Session
Signed by Governor
Bill Summary
Sponsors
Session
Regular Session 2014
Title
Muscular Dystrophy, Duchenne, Food and Drug Administration urged to grant accelerated approval for the drug eteplirsen for treatment
Description
Muscular Dystrophy, Duchenne, Food and Drug Administration urged to grant accelerated approval for the drug eteplirsen for treatment.
Subjects
Resolutions, Legislative
Bill Actions
| Action Date | Chamber | Action |
|---|---|---|
| March 12, 2014 | H | Assigned Act No. 2014-171. |
| March 12, 2014 | H | Signature Requested |
| March 12, 2014 | S | Enrolled |
| March 12, 2014 | S | Passed Second House |
| March 12, 2014 | H | McCutcheon motion to Concur In and Adopt adopted Voice Vote |
| March 12, 2014 | H | Reported from Rules |
| March 5, 2014 | H | Received in House of Representatives and referred to the House of Representatives committee on Rules |
| March 5, 2014 | S | Brewbaker motion to Adopt adopted Voice Vote |
| March 5, 2014 | S | Introduced |
Bill Text
Bill Documents
| Type | Link |
|---|---|
| Bill Text | SJR76 Alabama 2026 Session - Enrolled |
| Bill Text | SJR76 Alabama 2026 Session - Introduced |
Source: Alabama Legislature